Billings Clinic
Especially For:

Clinical Trials

Title   GI- Colorectal Cancer Adjuvant
Description   A Phase III Trial of 6 vs 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
IRB Number   CTSU C80702
Category   Gastrointestinal
Inclusion/Notes   Tumors must have been completely resected.

Patients are ineligible if they use NSAIDS at any dose or aspirin at more than 325 mg at least three times per week, on average. Low dose aspirin not exceeding 100 mg/day is permitted.

No history of upper gastrointestinal ulceration, bleeding, or perforation within the last 3 years.

Please contact Tricia Montgomery, RN for additional inclusion/exclusion criteria.
Status   Open
Start Date   08/30/2010
Principal Investigator (PI)   Roger Santala, MD
Contact Name   Liane Bates
Contact Email   lbates@billingsclinic.org
Phone   (406) 435-7481
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.